AccuStem Sciences, Inc. (ACUT)
OQB · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. The company offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. It also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.
Peers in Healthcare
AccuStem Sciences, Inc. has no peer companies in this window.
Recent press releases
AccuStem Sciences, Inc. has not issued a press release in this window.
SEC filings
All filings →AccuStem Sciences, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →AccuStem Sciences, Inc. has no reported insider trades in the last 90 days.